Literature DB >> 8455008

Use of erythropoietin in Jehovah's Witness children following acute gastrointestinal blood loss.

S N Smith1, D E Milov.   

Abstract

The decision to transfuse children in families practicing the Jehovah's Witness faith with human blood products raises medical, legal, and moral questions. Two cases are presented in which recombinant human erythropoietin was used in pediatric patients as an alternative following acute gastrointestinal hemorrhage. The patients demonstrated increased hematocrit levels obviating the need for blood transfusion. Although erythropoietin is not an alternative to hemotransfusion in the unstable patient, it may be an option in the hemodynamically uncompromised Jehovah's Witness patient following acute blood loss.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455008

Source DB:  PubMed          Journal:  J Fla Med Assoc        ISSN: 0015-4148


  1 in total

1.  Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia? A pilot study.

Authors:  Spiros D Ladas; Dimitrios Polymeros; Thomas Pagonis; Konstantinos Triantafyllou; Gregorios Paspatis; Maria Hatziargiriou; Sotirios A Raptis
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.